Abstract 4366745: Artificial Intelligence-Derived Myosteatosis on Coronary Artery Calcium CT Scans Predicts Incident COPD: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)
Abstract
Introduction/Background: Myosteatosis, defined as pathological fat infiltration into skeletal muscle, is an emerging marker of metabolic dysfunction and cardiovascular risk, particularly when measured in abdominal CT. However, its association with lung health and risk of chronic obstructive pulmonary disease (COPD) is not well established. The AI-CVD initiative aims to extract all useful opportunistic screening information from coronary artery calcium scans and combines them with traditional risk factors to create a stronger predictor of cardiovascular diseases. We hypothesized that myosteatosis measured from cardiac CT scans using AI-CVD is associated with increased risk of incident COPD in a population free of clinical cardiovascular disease at baseline. Methods/Approach: A retrospective cohort analysis was conducted using baseline data from Exam 1 of the Multi-Ethnic Study of Atherosclerosis including men and women aged 45 to 84 free of cardiovascular disease at baseline. Myosteatosis was quantified using AI-CVD to segment muscle and compute thoracic skeletal muscle density as a proxy for fat infiltration. Chronic obstructive pulmonary disease (COPD) was defined using clinical diagnosis with ICD codes. Proportional hazards models were used to assess the association between myosteatosis and incident COPD disease over 15 years. Models were adjusted for confounders including age, sex, pack years of smoking, emphysema, body mass index, inflammation, diabetes, and socioeconomic status. Results/Data: A total of 283 cases of incident COPD were identified. Individuals in the lowest quartile of muscle attenuation had significantly higher cumulative incidence compared to other quartiles. In minimally adjusted models, the hazard ratio comparing the lowest to highest quartile was 1.87. In fully adjusted models, the association remained significant with a hazard ratio of 1.32. Conclusion(s): AI-based quantification of myosteatosis on routine cardiac CT scans independently predicts future risk of COPD. Adverse muscle composition in the pectoralis, intercostal, and paraspinal muscles may precede lung function decline. Opportunistic assessment of myosteatosis could enable early identification of individuals at elevated risk and support preventive interventions at elevated risk for COPD and guide preventive strategies before clinical disease onset.
Article Details
Authors (30)
Morteza Naghavi
HeartLung Technologies, Houston, Texas, United States
Amir Azimi
Kyle Atlas
HeartLung Technologies, Houston, Texas, United States
Chenyu Zhang
Anthony Reeves
Cornell University, Ithaca , New York, United States
Jakob Wasserthal
University Basel, Basel, Switzerland
Nathan Wong
Claudia Henschke
Mount Sinai Hospital, New York, New York, United States
David Yankelevitz
Mount Sinai Hospital, New York, New York, United States
David Maron
Stanford University, Stanford, California, United States
Rozemarijn Vliegenthart
Michael McConnell
Stanford University, Palo Alto, California, United States
Javier Zulueta
Mount Sinai Hospital, New York, New York, United States
Kim Williams
Andrea Branch
Mount Sinai Hospital, New York, New York, United States
Jeffrey mechanick
icahn school of med at mount siani, New York, New York, United States
Ning Ma
Rowena Yip
Icahn School of Med at Mt Sinai, New York, New York, United States
Wenjun Fan
State Key Laboratory of Catalysis, Dalian Institute of Chemical Physics
Sion Roy
UCLA Harbor, Malibu, California, United States
Matthew Budoff
The Lundquist Institute, Torrance, California, United States
Sabee Molloi
University of California, Irvine, Irvine, California, United States
Ioannis Kakadiaris
UNIVERSITY OF HOUSTON, Houston, Texas, United States
Prediman Shah
Cedars-Sinai Medical Center, Los Angeles, California, United States
George Abela
MICHIGAN STATE UNIV, East Lansing, Michigan, United States
Jagat Narula
Emelia Benjamin
Boston University School Medicine, Brookline, Massachusetts, United States
Daniel Levy
Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Roxana Mehran
Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (R.M.).
Robert Kloner
Huntington Medical Research Inst., Pasadena, California, United States